Patient Leaflet Updated 06-Jan-2023 | Medice UK LTD
Medikinet XL modified release capsules, hard
Medikinet XL 5 mg modified-release capsules, hard
Medikinet XL 10 mg modified-release capsules, hard
Medikinet XL 20 mg modified-release capsules, hard
Medikinet XL 30 mg modified-release capsules, hard
Medikinet XL 40 mg modified-release capsules, hard
Medikinet XL 50 mg modified-release capsules, hard
Medikinet XL 60 mg modified-release capsules, hard
Methylphenidate hydrochloride
▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See the end of section 4 for how to report side effects.
The name of your medicine is Medikinet XL, it contains the active substance ‘methylphenidate hydrochloride’. The name ‘methylphenidate’ will also be used in the leaflet.
This medicine is used to treat ADHD
Read section 1 for more information.
Before you take this medicine, talk to your doctor if:
Read section 2 for more information.
While taking this medicine:
Read sections 3 and 4 for more information.
Talk to your doctor straight away if any of the following happen:
Read section 4 for more information.
Read all of this leaflet carefully before you or your child start taking this medicine because it contains important information for you.
See section 4.
The leaflet has been written in sections:
However, all sections are written as though the child or young person taking the medicine is reading them.
What is in this leaflet:
1. What MEDIKINET XL is and what it is used for
2. What you need to know before you or your child takes MEDIKINET XL
3. How to take MEDIKINET XL
4. Possible side effects
5. How to store MEDIKINET XL
6. Contents of the pack and other information
Information for children and young people
Now read the rest of this leaflet before you start taking this medicine.
MEDIKINET XL is used to treat ‘attention deficit hyperactivity disorder’ (ADHD).
MEDIKINET XL is not for use as a treatment for ADHD in children under 6 years of age.
MEDIKINET XL improves the activity of certain parts of the brain which are under-active. The medicine can help improve attention span and concentration and reduce impulsive behaviour.
The medicine is given as part of a treatment programme, which usually includes psychological, educational and social therapy.
MEDIKINET XL treatment must only be initiated by, and used under the supervision of a doctor, specialised in the treatment of ADHD, such as an expert paediatrician, a child and adolescent psychiatrist or a psychiatrist. A careful examination by this doctor is required. If you as an adult have not been treated before, the doctor will perform tests to confirm that you have been affected by ADHD since childhood. Although there is no cure for ADHD, it can be managed using treatment programmes.
Children and young people with ADHD find it:
It is not their fault that they cannot do these things.
Patients can have ADHD in varying degrees with symptoms including:
This is shown by, for example:
ADHD does not affect the intelligence of a child or young person.
Do not take methylphenidate if any of the above apply to you or your child. If you are not sure, talk to your doctor or pharmacist before you or your child takes methylphenidate. This is because methylphenidate can make these problems worse.
Talk to your doctor before taking MEDIKINET XL if you or your child
Tell your doctor or pharmacist if any of the above apply to you or your child before starting treatment. Methylphenidate can make these problems worse. Your doctor will want to monitor how the medicine affects you or your child.
These checks are to decide if methylphenidate is the correct medicine for you or your child. Your doctor will talk to you about:
Your doctor will discuss whether you or your child is at risk of having mood swings (from being manic to being depressed - called ‘bipolar disorder’). They will check you or your child’s mental health history, and check if any of your family have a history of suicide, bipolar disorder or depression.
It is important that you provide as much information as you can. This will help your doctor decide if methylphenidate is the correct medicine for you or your child. Your doctor may decide that other medical tests are needed before you or your child start taking this medicine.
During treatment, boys and adolescents may unexpectedly experience prolonged erections. This may be painful and can occur at any time. It is important to contact your doctor straight away if your erection lasts for longer than 2 hours, particularly if this is painful.
This medicine may give a positive result when testing for drug use.
Athletes must be aware that this medicinal product may cause a positive reaction to ‘anti-doping’ tests.
Please tell your doctor or pharmacist if you or your child is taking, has recently taken or may take any other medicines.
If you or your child is taking other medicines, methylphenidate may affect how well they work or may cause side effects. Tell your doctor if you or your child is taking medicines to treat:
MEDIKINET XL must not be taken together with H2 receptor blockers, proton pump inhibitors or antacids which are used to reduce gastric acid secretion or to counteract excessive acitity in the stomach, as this could lead to a faster release of the total amount of active substance.
If you are in any doubt about whether any medicines you or your child is taking are included in the list above, ask your doctor or pharmacist for advice before taking methylphenidate.
Tell your doctor if you or your child is going to have an operation. Methylphenidate should not be taken on the day of surgery if a certain type of anaesthetic is used. This is because there is a chance of a sudden rise in blood pressure during the operation.
Do not drink alcohol while taking this medicine. Alcohol may make the side effects of this medicine worse. Remember that some foods and medicines contain alcohol.
Available data do not suggest an increased risk of overall birth defects, whilst a small increase in the risk of malformations of the heart when used during the first three months of pregnancy could not be ruled out. Your doctor will be able to give you more information about this risk. Tell your doctor or pharmacist before using methylphenidate if you or your daughter:
You or your child may feel dizzy, have problems focussing or have blurred vision when taking methylphenidate. If these happen it may be dangerous to do things such as drive, use machines, ride a bike or horse or climb trees.
If you or your child has been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
You or your child should always take MEDIKINET XL exactly as your doctor has told you. You should check with your doctor or pharmacist if you are not sure.
Use in children
The maximum daily dose is 60 mg.
Use in adults
For adults who have taken MEDIKINET XL before
For adults who have not taken MEDIKINET XL before
The recommended starting dose is 10 mg daily.
Your doctor will do some tests
The medicinal product is intended for oral use.
Children take MEDIKINET XL in the morning with or after breakfast.
Adults take MEDIKINET XL with or after breakfast and lunch.
MEDIKINET XL is a form of methylphenidate with “controlled release“ action which releases the drug gradually over a prolonged period of time. Taking the capsule with or after meals is very important in order for their action to be delayed.
The capsules may be swallowed whole with a drink of water. Alternatively, you can open the capsules, sprinkle the contents onto a small amount (tablespoon) of applesauce or yoghurt and take it immediately. Do not store for future use.
The capsules and the capsule contents must not be crushed or chewed.
If you or your child does not feel better, tell your doctor. They may decide a different treatment is needed.
MEDIKINET XL does not need to be taken for ever. If you or your child takes MEDIKINET XL for more than a year, your doctor should stop treatment at least once per year for a short time. In case of children this may happen during a school holiday. This will show if the medicine is still needed.
If MEDIKINET XL is not used properly, this may cause abnormal behaviour. It may also mean that you or your child starts to depend on the medicine. Tell your doctor if you or your child has ever abused or been dependent on alcohol, prescription medicines or street drugs.
If you or your child takes too much of the medicine, talk to a doctor or call an ambulance straight away. Tell them how much has been taken.
Signs of overdose may include: being sick, feeling agitated, shaking, increased uncontrolled movements, muscle twitching, fits (may be followed by coma), feeling very happy, being confused, seeing, feeling or hearing things that are not real (hallucinations), sweating, flushing, headache, high fever, changes in heart beat (slow, fast or uneven), high blood pressure, dilated pupils and dry nose and mouth.
Do not take a double dose to make up for a forgotten dose. If you or your child forgets a dose, wait until it is time for the next dose.
If you or your child suddenly stops taking this medicine, ADHD symptoms may come back or unwanted effects such as depression may appear. Your doctor may want to gradually reduce the amount of medicine taken each day, before stopping it completely. Talk to your doctor before stopping MEDIKINET XL.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, but not everybody gets them. Your doctor will talk to you about these side effects.
Some side effects could be serious. If you have any of the side effects below, see a doctor straight away:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Not known: frequency cannot be estimated from available data
If you have any of the side effects above, see a doctor straight away.
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Not known: frequency cannot be estimated from available data
When used for more than a year, methylphenidate may cause reduced growth in some children.
This affects less than 1 in 10 children.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and the box after “EXP”.
The expiry date refers to the last day of that month.
Do not store above 30 °C.
Store in the original package in order to protect from moisture.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help to protect the environment.
The active substance is: methylphenidate hydrochloride
MEDIKINET XL 5 mg modified-release capsules, hard
Each modified-release capsule, hard contains 5 mg methylphenidate hydrochloride equivalent to 4.35 mg methylphenidate.
MEDIKINET XL 10 mg modified-release capsules, hard
Each modified-release capsule, hard contains 10 mg methylphenidate hydrochloride equivalent to 8.65 mg methylphenidate.
MEDIKINET XL 20 mg modified-release capsules, hard
Each modified-release capsule, hard contains 20 mg methylphenidate hydrochloride equivalent to 17.30 mg methylphenidate.
MEDIKINET XL 30 mg modified-release capsules, hard
Each modified-release capsule, hard contains 30 mg methylphenidate hydrochloride equivalent to 25.95 mg methylphenidate.
MEDIKINET XL 40 mg modified-release capsules, hard
Each modified-release capsule, hard contains 40 mg methylphenidate hydrochloride equivalent to 34.60 mg methylphenidate.
MEDIKINET XL 50 mg modified-release capsules, hard
Each modified-release capsule, hard contains 50 mg methylphenidate hydrochloride equivalent to 43.25 mg methylphenidate.
MEDIKINET XL 60 mg modified-release capsules, hard
Each modified-release capsule, hard contains 60 mg methylphenidate hydrochloride equivalent to 51.90 mg methylphenidate.
The other ingredients are:
Capsule content:
Sugar spheres (containing sucrose and maize starch), Methacrylic acid-ethylacrylate-copolymer (1:1), Talc, Triethyl citrate, Poly(vinyl alcohol), Macrogol 3350, Polysorbate 80, Sodium hydroxide, Sodium laurilsulfate, Simeticone, Silica colloidal anhydrous, Methylcellulose, Sorbic acid, Indigo carmine, aluminium lake (E 132)
Capsule shell:
Gelatin, Titanium dioxide (E 171), Sodium laurilsulfate, Purified water
additional in the capsule shell of MEDIKINET XL 10 mg /- 20 mg:
Erythrosine (E 127), Patent blue V (E 131)
additional in the capsule shell of MEDIKINET XL 30 mg /- 40 mg /- 50 mg /- 60 mg:
Erythrosine (E 127), Iron oxide black (E 172), Indigo carmine (E 132)
MEDIKINET XL 5 mg modified-release capsules, hard
White opaque capsule body/white opaque capsule cap (15.9 mm) containing white and blue pellets.
MEDIKINET XL 10 mg modified-release capsules, hard
White opaque capsule body/mauve opaque capsule cap (15.9 mm) containing white and blue pellets.
MEDIKINET XL 20 mg modified-release capsules, hard
Mauve opaque capsule body/mauve opaque capsule cap (15.9 mm) containing white and blue pellets.
MEDIKINET XL 30 mg modified-release capsules, hard
Light grey opaque capsule body/dark violet opaque capsule cap (15.9 mm) containing white and blue pellets.
MEDIKINET XL 40 mg modified-release capsules, hard
Grey opaque capsule body/dark violet opaque capsule cap (18.0 mm) containing white and blue pellets.
MEDIKINET XL 50 mg modified-release capsules, hard
Violet opaque capsule body/dark violet opaque capsule cap (18.0 mm) containing white and blue pellets.
MEDIKINET XL 60 mg modified-release capsules, hard
Dark violet opaque capsule body/dark violet opaque capsule cap (19.4 mm) containing white and blue pellets.
Pack sizes:
MEDIKINET XL 5 mg modified-release capsules, hard
Boxes containing 20, 30 or 50 modified-release capsules, hard packed in blisters made of PVC/PVdC aluminium foil.
MEDIKINET XL 10 mg /- 20 mg /- 30 mg /- 40 mg modified-release capsules, hard Boxes containing 20, 28, 30 or 50 modified-release capsules, hard packed in blisters made of PVC/PVdC aluminium foil.
MEDIKINET XL 50 mg /- 60 mg modified-release capsules, hard
Boxes containing 20, 28, 30, 40 modified-release capsules, hard packed in blisters made of PVC/PVdC aluminium foil.
Not all pack sizes may be marketed.
This medicinal product is authorised in the Member States of the EEA under the following names:
Germany: Medikinet retard 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Hartkapseln mit veränderter Wirkstofffreisetzung
Austria: Medikinet retard 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Hartkapseln mit veränderter Wirkstofffreisetzung
Denmark: Medikinet CR 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Spain: Medikinet 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
cápsulas duras de liberación modificada
Finland: Medikinet CR 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Iceland: Medikinet CR 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
hart hylki með breyttan losunarhraða
Luxembourg: Medikinet retard 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Hartkapseln mit veränderter Wirkstofffreisetzung
Netherlands: Medikinet CR 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
capsule met gereguleerde afgifte, hard
Norway: Medikinet 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Kapsel med modifisert frisetting, hard
Poland: Medikinet CR 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Sweden: Medikinet 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
Kapsel med modifierad frisättning, hård
United Kingdom: Medikinet XL 5 mg, 10 mg, 20 mg, 30 mg, 40 mg, 50 mg, 60 mg
modified-release capsule, hard
This leaflet was last revised in 08/2020
This info is to help you learn the main things about your medicine called MEDIKINET XL. If you don’t enjoy reading, someone like your mum, dad or carer (sometimes called ‘your guardian’) can read it to you and answer any questions.
It may help if you read small bits at a time.
This medicine can help children and young people with ‘ADHD’.
You cannot have this medicine if:
You need to talk to your doctor if:
Side effects are the unwanted things that can happen when you take a medicine. If any of the following happen, tell an adult you trust straight away. They can then talk to your doctor. The main things that could affect you are:
If you feel unwell in any way while you are taking your medicine please tell an adult you trust straight away.
Your mum, dad, carer, doctor, nurse or pharmacist will be able to help you.
403006061409
The Rotunda, 1 Old London Road, Hertford, Hertfordshire, SG13 7LA, UK
0204 582 2845
0204 582 2845